Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR+31.8%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+31.8%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
4x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202518.74%
202412.83%
202355.37%
2022-98.28%
2021-51.74%
20204.71%
2019-18.28%
201838.44%
201711.94%
201639.24%